Influencing Factors of Cerebrovascular Disease and Cognition in Hemodialysis Patients
NCT ID: NCT04433455
Last Updated: 2024-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
20 participants
OBSERVATIONAL
2020-06-01
2025-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Emotion and Cognitive Function and Brain Imaging Change in HD Patients
NCT05137470
Assessing Cognitive fUnction and MEasuring the Cerebral circulatioN on HaemoDialysis
NCT02393222
Interaction Research on Cognitive Impairment and Emotional Disorder in End-stage Renal Disease
NCT03191409
Cognitive and Functional Status and Dialysis Outcomes in Older Hemodialysis Patients
NCT00739843
Early Detection, Remote Augmented Reality Combined Rehabilitation Therapy, and Translational Therapy for Patients With Chronic Kidney Disease and Cognitive Disorder
NCT07272733
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. dialysis vintage is greater than 3 months;
Exclusion Criteria
2. Those with severe mental illness, metabolic diseases and immune system diseases;
3. Patients with abnormal liver function
50 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Huashan Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Chen Jing
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jing Chen
Role: PRINCIPAL_INVESTIGATOR
Huashan Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Huashan Hospital
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Qian Zhang
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
KY2019-465
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.